David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Meta Platforms (Facebook)
META
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
T-Mobile US
TMUS
|
+$416M |
| 5 |
Uber
UBER
|
+$350M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$547M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$490M |
| 3 |
Johnson & Johnson
JNJ
|
+$444M |
| 4 |
Apple
AAPL
|
+$435M |
| 5 |
Accenture
ACN
|
+$378M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.7% |
| 2 | Consumer Discretionary | 8.8% |
| 3 | Healthcare | 8.52% |
| 4 | Financials | 6% |
| 5 | Industrials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Moderna
MRNA
$63.4B
| $9.54M | 0.01% |
78,507
-189,573
| -71% | -$25.3M |
|
1277
Armstrong World Industries
AWI
$7.6B
| $9.54M | 0.01% |
129,801
+124,393
| +2,300% | +$8.47M |
|
1278
Resideo Technologies
REZI
$3.03B
| $9.52M | 0.01% |
539,268
+22,747
| +4% | +$393K |
|
1279
Arrow Electronics
ARW
$10.3B
| $9.52M | 0.01% |
66,450
-97,294
| -59% | -$12.1M |
|
1280
D.R. Horton
DHI
$42.2B
| $9.51M | 0.01% |
78,129
-188,850
| -71% | -$20.6M |
|
|
MRTX
1281
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.5M | 0.01% |
262,938
+17,352
| +7% | +$715K |
|
|
NVMI
1282
Nova
NVMI
$11.7B
| $9.49M | 0.01% |
80,885
+18,393
| +29% | +$1.88M |
|
1283
PUT
Unum
UNM
$14.2B
| $9.49M | 0.01% |
198,900
+138,100
| +227% | +$6.03M |
|
1284
Acadia Healthcare
ACHC
$2.78B
| $9.45M | 0.01% |
118,673
+46,761
| +65% | +$3.38M |
|
|
AVNS
1285
DELISTED
Avanos Medical
AVNS
| $9.45M | 0.01% |
369,565
-147,816
| -29% | -$3.89M |
|
1286
Bath & Body Works
BBWI
$3.54B
| $9.44M | 0.01% |
251,771
+76,701
| +44% | +$2.8M |
|
1287
Winnebago Industries
WGO
$901M
| $9.4M | 0.01% |
140,937
-1,409
| -1% | -$84.1K |
|
1288
Pulmonx
LUNG
$107M
| $9.39M | 0.01% |
716,378
+142,214
| +25% | +$1.74M |
|
1289
CALL
TransDigm Group
TDG
$65.9B
| $9.39M | 0.01% |
+10,500
| New | +$8.3M |
|
|
SPLK
1290
CALL
DELISTED
Splunk Inc
SPLK
| $9.37M | 0.01% |
88,300
-4,200
| -5% | -$399K |
|
1291
Brady Corp
BRC
$4.41B
| $9.35M | 0.01% |
+196,494
| New | +$9.88M |
|
1292
Nasdaq
NDAQ
$55.2B
| $9.34M | 0.01% |
187,300
-363,606
| -66% | -$19.7M |
|
1293
Expeditors International
EXPD
$24.6B
| $9.33M | 0.01% |
77,057
+37,973
| +97% | +$4.32M |
|
1294
Moody's
MCO
$88.9B
| $9.33M | 0.01% |
26,832
+12,434
| +86% | +$3.94M |
|
1295
Badger Meter
BMI
$3.95B
| $9.32M | 0.01% |
63,192
+55,243
| +695% | +$7.61M |
|
1296
Alcon
ALC
$35.5B
| $9.32M | 0.01% |
113,553
-295,860
| -72% | -$22.6M |
|
1297
Allegro MicroSystems
ALGM
$6.98B
| $9.26M | 0.01% |
205,129
-172,183
| -46% | -$6.97M |
|
|
AVDX
1298
DELISTED
AvidXchange
AVDX
| $9.25M | 0.01% |
891,092
-371,681
| -29% | -$3.34M |
|
1299
PUT
Peloton Interactive
PTON
$2.36B
| $9.24M | 0.01% |
1,201,900
+279,600
| +30% | +$2.38M |
|
|
KRTX
1300
PUT
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $9.24M | 0.01% |
42,600
+4,900
| +13% | +$1.05M |
|
Similar funds
David Shaw's Q2 2023 Portfolio in Review
As of Q2 2023, David Shaw held 4,841 positions worth $97.9B, up 4.8% from $93.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $4.46B in Q2 2023, closing 639 positions and reducing 1,586 holdings. Its most notable exit was Shaw Communications Inc., an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Oracle worth $217M.
- David Shaw's largest Q2 2023 buy was Oracle: 1,825,762 shares worth $217M.
- David Shaw added most to NVIDIA in Q2 2023, an estimated $997M increase.
- David Shaw's biggest Q2 2023 reduction was Visa, cutting an estimated $547M.
- David Shaw fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $152M.
- David Shaw's ten largest holdings make up 12% of its $97.9B portfolio in Q2 2023.
- David Shaw opened 467 new positions and closed 639 in Q2 2023.
- David Shaw's portfolio value rose 4.8% quarter-over-quarter to $97.9B.
Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.